Medicines / Mankind Pharmaceuticals / Romplio
RomplioRomiplostim
Romplio is marketed by Mankind Pharmaceuticals. 2 packs on NPPA's price list for July 2026, containing Romiplostim.
- Packs listed
- 2
- Lowest MRP
- ₹4,275
- Per unit
- ₹4,275 to ₹7,775
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹4,275Romplio 250 mg Injection 1Romiplostim Injection 250 mg · ₹4,275 per injection
- ₹7,775Romplio 500 mg Injection 1Romiplostim Injection 500 mg · ₹7,775 per injection
The company
Mankind Pharmaceuticals has 1,973 packs on the price list, and CDSCO has named it as the manufacturer of 6 failed batches since Aug 2014. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.